Management of disseminated kidney cancer

S. S. Taneja, W. Pierce, R. Figlin, A. Belldegrun

Research output: Contribution to journalReview articlepeer-review


The approach to disseminate renal cell carcinoma (RCC) has evolved significantly in recent years, largely owing to the progress of biologic therapy development. With increasing knowledge of biologic therapy come several dilemmas, including the choice of cytokine therapy, the appropriate mode of delivery, the selection of candidates for given therapeutic options, and the role of cytoreductive nephrectomy in immunotherapy protocols. This article reviews the historical development of immunotherapy and the lessons learned from previous experience and offers a logical approach to the patient with disseminated RCC.

Original languageEnglish (US)
Pages (from-to)625-637
Number of pages13
JournalUrologic Clinics of North America
Issue number4
StatePublished - 1994

ASJC Scopus subject areas

  • Urology


Dive into the research topics of 'Management of disseminated kidney cancer'. Together they form a unique fingerprint.

Cite this